How Brazil joined the quest for a yellow fever vaccine

dc.creatorBenchimol, Jaime Larry
dc.date2022-06-27T13:46:50Z
dc.date2022-06-27T13:46:50Z
dc.date2013
dc.date.accessioned2023-09-26T23:05:10Z
dc.date.available2023-09-26T23:05:10Z
dc.identifierBENCHIMOL, J. L. How Brazil joined the quest for a yellow fever vaccine. [ Entrevista cedida a] Claudia Jurberg e Julia D'Aloisio. Bull World Health Organ, Genebra, v. 91, n. 3, p. 165-166, mar. 2013.
dc.identifier0042-9686
dc.identifierhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590627/?report=classic
dc.identifier10.2471/BLT.13.030313
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8886668
dc.descriptionO Brasil anunciou recentemente um acordo entre sua unidade de vacinas de Bio-Manguinhos e duas empresas norte-americanas para pesquisar e desenvolver uma nova vacina contra a febre amarela. Claudia Jurberg e Julia D'Aloisio conversam com Jaime Benchimol sobre a polêmica história do desenvolvimento da vacina que hoje beneficia milhões de pessoas.
dc.descriptionBrazil recently announced an agreement between its Bio-Manguinhos vaccine unit and two US companies to research and develop a new yellow fever vaccine. Claudia Jurberg and Julia D’Aloisio talk to Jaime Benchimol about the controversial history of the development of the vaccine that benefits millions of people today.
dc.formatapplication/pdf
dc.languagepor
dc.relationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590627/?report=classic
dc.rightsopen access
dc.subjectFebre amarela
dc.subjectVacina
dc.subjectHistoriador da Saúde
dc.subjectHistória
dc.subjectEntrevista
dc.subjectYellow Fever
dc.subjectVaccine
dc.subjectHealth Historian
dc.subjectHistory
dc.subjectInterview
dc.subjectFebre Amarela/história
dc.subjectVacina contra Febre Amarela
dc.subjectEntrevista
dc.titleHow Brazil joined the quest for a yellow fever vaccine
dc.typeArticle


Este ítem pertenece a la siguiente institución